Due to the number of positive COVID-19 cases and hospitalizations across the country and locally, Linn County has closed most buildings to the public to help reduce community spread of the virus and to help ensure continuity of County services.
Learn how to access remote services.
Create an Account - Increase your productivity, customize your experience, and engage in information you care about.
Show All Answers
It is the role of Linn County Public Health (LCPH) to plan for and respond to pandemics, along with our response partners. When vaccine is available, it is LCPH’s job to work with community partners to identify where to direct any available vaccine within the county, and ensure it is given appropriately.
LCPH works with providers to allocate vaccine, but does not oversee their appointment process. Local providers have their own process for contacting patients and making vaccine appointments:
LCPH must be able to change plans quickly to meet state and federal guidelines. LCPH does not control how much vaccine is available to the county. In some cases, local health departments also give vaccine.
Currently, community members are not able to sign up for COVID-19 vaccine in advance through Linn County Public Health (LCPH). As vaccine supplies increase in the coming weeks, we will continue to coordinate this distribution of available vaccine to local vaccine providers and will continue to notify our community as populations become eligible to receive vaccine.
If you are eligible for vaccine through your employer as part of Phase 1B Tiers and your employer has completed the COVID-19 Vaccine Registry form for Employers, your employer will be contacted when vaccine is available.
Providers with vaccine have begun contacting eligible patients. While many of our residents may now be eligible to receive vaccine, many will not get a call right away from their provider to schedule an appointment or – depending on the provider - be able to sign up online for an appointment time. Not all providers have vaccine to offer, and those that do have very limited amounts.
Local Vaccine Providers
For persons 65 years and older who do not have a primary care provider, LCPH will assist with locating a vaccine provider. Those individuals should call (319) 892-6097 for assistance or may contact:
Vaccine Provider Appointments
Frequently check your healthcare provider’s website for information and instructions for scheduling appointments:
Eastern Iowa Health Center is contacting eligible patients by phone, text and email to schedule appointments.
Mercy Cedar Rapids is contacting a list of Mercy and MercyCare patients with MyChart as vaccine supply allows.
Unity Point Health Cedar Rapids is contacting primary care patients by mail, phone, and text as vaccine supply allows.
The Retail Pharmacy Program began the week of February 8, 2021 in Iowa. Hy-Vee and CPESN pharmacies (Clark’s Pharmacy) have been selected by the Centers for Disease Control and Prevention as the pharmacy providers for this program. Additional pharmacies will be added at a later date.
Subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe. In addition to the Linn County COVID-19 website, updates will also be shared on Facebook and Twitter.
Subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe. In addition to the Linn County COVID-19 website, updates will also be shared on Facebook and Twitter. Additionally, stay tuned to local news outlets for updated information.
Providers with vaccine have begun contacting eligible patients via phone, mail, or through notifications such as MyChart to inform them of vaccine availability. Vaccine availability may also be listed on healthcare provider’s websites. While many of our residents may now be eligible to receive vaccine, many will not get a call right away from their provider to schedule an appointment or – depending on the provider - be able to sign up online for an appointment time. Not all providers have vaccine to offer, and those that do have very limited amounts.
If you are eligible for vaccine through your employer and your employer has completed the COVID-19 Vaccine Registry form for Employers, your employer will be contacted when vaccine is available. Learn more about who is currently eligible for vaccine through their employer.
For general updates, subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe. In addition to the Linn County COVID-19 website, updates will also be shared on Facebook and Twitter. Additionally, stay tuned to local news outlets for current information.
The first doses of COVID-19 vaccine arrived in Linn County on December 15, 2020. This began the first phase, or Phase 1A, of vaccine distribution in our community. Because the supply of vaccine is very limited, a phased approach is being used to offer vaccine to populations most at risk. Populations to receive vaccine in the first phase were healthcare workers and residents and staff of long-term care facilities. As we slowly move into Phase 1B, we will continue to ensure Phase 1A populations that have not received their vaccine will continue to be offered a vaccination.
Yes. With more shipments of vaccine expected in the following months, vaccine will eventually be available to anyone who wants it.
Linn County Public Health will share information about when vaccine will be given to more groups within the general public once that information is available from federal and state partners. Subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe.
Linn County began Phase 1B on February 1. Supply challenges continue to affect the ability to immediately provide COVID-19 vaccine to all eligible populations. The Iowa Department of Public Health (IDPH) released Phase 1B priority population recommendations on January 12. These initial recommendations included prioritizing Iowans age 75 and older, and other Iowans who are vulnerable to high risk of exposure to COVID-19 or severity of illness as the result of a COVID-19 infection. On January 21, Governor Kim Reynolds announced that Iowans age 65 years and over will also be included in Phase 1B to further expand eligibility of older adults. Vaccine remains in short supply. This means that it may take weeks to months for populations in the Governor’s Phase 1B to receive vaccine. More information on the tiers of Phase 1B can be found on the Linn County Public Health website.
All Eligible Populations
Federal, state and local health experts have been prioritizing populations to receive vaccine while vaccine supply remains low. Iowans who are vulnerable to high risk of exposure to COVID-19, or severity of illness as the result of a COVID-19 infection will begin to receive the vaccine first. If you are offered vaccine, it is recommended that you receive your vaccine. Vaccine supply is expected to increase substantially in 2021 and eventually be available to everyone who wants to receive it.
Yes. While COVID-19 vaccine supply is limited, Linn County Public Health (LCPH) is following federal and state recommendations for vaccine rollouts. Demand for vaccine is far greater than the supply coming into our community. COVID-19 vaccine supplies are arriving to our state and county very slowly and in limited quantity. Vaccine supply is expected to increase substantially in 2021 and eventually be available to everyone who wants to receive it. However, it is our understanding vaccine may slowly trickle in with larger quantities available beginning late spring. Therefore, it will take some time for our community to move through vaccine distribution as vaccine manufacturers ramp up production, while more finish clinical studies and are approved for use.
While COVID-19 vaccine supply is limited, Linn County Public Health (LCPH) is following federal and state recommendations for vaccine rollouts. First, priority groups are recommended by the Advisory Committee on Immunization Practices (ACIP) when vaccine supply is limited. ACIP presents their recommendations to the Centers for Disease Control and Prevention (CDC).
On January 11, Iowa issued a vaccine shortage order - which included prioritizing Iowans age 75 and older - and other Iowans who are vulnerable to exposure to COVID-19 or high-risk for illness as the result of a COVID-19 infection. These 1B populations were eligible to begin to receive vaccine by February 1, 2021. On January 21, Governor Kim Reynolds announced that Iowans age 65 years and over will also be included in phase 1B to further expand eligibility of older adults.
Linn County Public Health will share information about when vaccine will be given to more groups within the general public once that information is available from federal and state partners. Subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe. In addition to the Linn County COVID-19 website, updates will also be shared on Facebook and Twitter.
Due to the limited supply of vaccine, vaccine will be prioritized to those most at risk using a phased approach. The following phases have been recommended by the Iowa Department of Public Health (IDPH).
Populations included within Phase 1A:
Populations included within Phase 1B:
The Iowa Infectious Disease Advisory Council has recommended priority populations for Phase 1C, which include individuals 65 years of age and older and individuals 64 years of age and younger with underlying medical conditions that are or may be an increased risk of severe illness from COVID-19.
Linn County began Phase 1B on February 1.
To be notified of when Linn County will move to the next phase, subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe. This information will also be posted on Linn County’s website, on Facebook and on Twitter.
Each state has their own vaccination plan. These plans identify who is eligible to receive the vaccine in each phase, while supply of the vaccine is limited, and are updated when more information becomes available. While most states are using federal recommendations from the CDC’s Advisory Committee on Immunization Practices (ACIP), a few states are not. Linn County Public Health is following both CDC and Iowa Department of Public Health recommendations of prioritization for this phased approach.
The first 2 COVID-19 vaccines approved for use in the U.S. are messenger ribonucleic acid (mRNA) vaccines. mRNA vaccines are a new type of vaccine. Instead of using a weakened or dead version of the COVID-19 virus, they use a small strip of genetic code — the mRNA. This code teaches the body to make the spike protein found on the COVID-19 virus. Once the immune system recognizes the spike protein, it creates proteins that fight the infection. These are called antibodies and will recognize if COVID-19 enters the body. Simply put, this helps your immune system to recognize and fight off the virus if it enters your body.
No. At this time vaccine supplies are limited and it is important to get vaccines administered as quickly as possible. In the initial phases of vaccine distribution, those that choose to get a vaccine will be given the vaccine that is available at the time. Currently, both vaccines approved for use are two dose vaccines. Individuals who choose to be vaccinated will be given the same vaccine for both doses.
No. If you are getting a COVID-19 vaccine, you should not receive other vaccines at that time. It’s recommended you should wait 14 days before, or after, getting other vaccines before receiving a vaccine for COVID-19.
There are many benefits of getting a COVID-19 vaccine when offered to you.
COVID-19 vaccines are not currently approved for young children. The Pfizer-BioNTech vaccine is not approved for people under the age of 16. The Moderna vaccine is not approved for people under the age of 18. Clinical trials to study how well the vaccine works have not been completed in infants, toddlers or kids in the Unites States.
The CDC has indicated that the vaccine may be given to those who are pregnant. If you are pregnant, trying to get pregnant or are currently breastfeeding, you may want to talk to your healthcare provider about getting the vaccine. This is because pregnancy is a medical condition that typically excludes people from participating in clinical trials to study the safety and effectiveness of a drug. Excluding this group of people means there is little data available at this time. While there are currently no known risks of getting the COVID-19 vaccine while pregnant, scientist are in the process of gathering additional data to learn more. Read more from the CDC about vaccine while pregnant or breastfeeding.
No. Not only is disinformation spreading around the internet claiming that COVID-19 vaccines cause infertility or miscarriage incorrect, this claim is also not medically possible. Infertility is not known to occur as a result of natural COVID-19 disease. This means that the immune response to the virus, whether created from an infection or by a vaccine, does not cause infertility.
The mRNA COVID-19 vaccines contain a small piece of the SARS-CoV-2 virus’s genetic material that instructs cells in the body to make the virus’s distinctive “spike” protein. After a person is vaccinated, their body produces copies of the spike protein, which does not cause disease, and triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2. Contrary to false reports on social media, this protein is not the same as any involved in formation of the placenta. Learn more.
Vaccine is currently only available to healthcare personnel, residents of long-term care facilities, individuals who are age 65 and over, and other high risk populations identified in Phase 1B.
For persons 65 years and older who do not have a primary care provider, Linn County Public Health will assist with locating a vaccine provider. Those individuals should call (319) 892-6097 for assistance or may contact:
Subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe. In addition to the Linn County COVID-19 website, updates will also be shared on Facebook and Twitter. Stay tuned to local news outlets for current information.
Eastern Iowa Health Center is contacting patients 65+ by phone, text and email to schedule appointments. Eligible patients and community members may also schedule appointments over the phone by dialing (319) 730-7300, #6. Learn more at https://easterniowahealthcenter.com/COVID19/vaccine/.
Mercy Medical Center is directing patients 65+, who are now eligible to receive vaccine, to their website. Mercy will open appointments to receive the vaccine as supply allows, which it anticipates will occur on a weekly basis. Supply allocations have been limited but, when available, qualified individuals can go to www.mercycare.org/covidvaccine to register online for an appointment. You do not need a MyChart account to register and can continue as a guest. If there are no appointments currently available, please check back regularly. Please do not call your primary care clinic or walk-in for vaccine. If you have additional questions or need assistance making an appointment, please call (319) 369-4604 to reach Mercy’s vaccine clinic call center.
Unity Point Health Cedar Rapids is contacting primary care patients 65+ by mail, phone and text as vaccine supply allows. Eligible patients experiencing technical difficulties may call (319) 730-9439.
The Retail Pharmacy Program began the week of February 8, 2021 in Iowa. Hy-Vee (and CPESN) pharmacies have been selected by the Centers for Disease Control and Prevention as the pharmacy providers for this program. Select Hy-Vee stores are now offering vaccine appointments for those who are 65 and older.
Clark’s Pharmacy has a link to add your name to the waitlist at www.clarksrxcr.com. Email is not required for the waitlist, but phone number is required.
Due to the limited supply of vaccine, mass vaccination clinics for the general public are not planned at this time. Once vaccine supply substantially increases, Linn County Public Health will use the strategies that are best to get vaccine to our community quickly, safely, and fairly.
Licensed providers interested in dispensing vaccine must complete an application from the Iowa Department of Public Health to administer COVID-19 vaccine. To date, nearly 100 independent providers and organizations in Linn County have applied and been approved through the state to give COVID-19 vaccine with the current model of vaccine distribution.
More information will be shared as healthcare provider applications are completed and prepared for public roll out. Subscribe to receive local COVID-19 Status Updates by using our NotifyMe tool and selecting "COVID-19 Status Update" under the News Flash category. View a step by step Instructional Video on how to subscribe. In addition to the Linn County COVID-19 website, updates will also be shared on Facebook and Twitter.
Linn County providers should contact Julie Stephens for assistance. Providers outside of Linn County should follow instructions for healthcare providers on the Iowa Department of Public Health COVID-19 Vaccine Information webpage: https://idph.iowa.gov/Emerging-Health-Issues/Novel-Coronavirus/Vaccine.
Due to limited amount of vaccine available, appointments are required at all vaccine provider locations and are anticipated to fill quickly. Each provider has their own process for making vaccine appointments available to individuals 65 and older. Documentation needed for your appointment will depend on the provider your vaccination appointment is scheduled with. When you schedule your appointment online, be sure to read all the information provided to you at the time of scheduling. If you have scheduled your appointment over the phone, be sure to ask if you need to bring a form of identification with you to your appointment.
If your vaccine appointment is scheduled through your employer, as they will be for individuals in Phase 1B Tiers, please ask your management team if you need to bring a form of identification, such as a driver’s license or work ID, to your appointment.
No. Immigration status does not matter. DHS encourages all individuals, regardless of immigration status, to receive the COVID-19 vaccine once eligible under local distribution guidelines. Learn more.
Vaccine paid for with U.S. taxpayer dollars will be given to the American people at no cost (free). Providers that participate in the CDC COVID-19 Vaccination Program agree to give the vaccine regardless of someone’s ability to pay or their insurance status. In some cases, a provider may charge a small fee to you or your health insurance for the administration of the vaccine, but they must not ask to be reimbursed from a vaccine recipient.
Safety is the top priority for any vaccine. Early results from the first COVID-19 vaccines tested in people showed it worked as intended with no serious side effects. New vaccines go through a series of tests during clinical trials. This data is then reviewed to make sure the vaccine is safe and effective. This is the process of all vaccines that come to market and the process to develop COVID-19 vaccines have been no different.
Learn more from the Centers for Disease Control and Prevention.
Yes. Health officials believe that the Pfizer and Moderna vaccines will offer protection against different COVID-19 variants. So far, studies suggest that the antibodies produced through vaccination with these currently authorized vaccines do recognize identified COVID-19 variants. Research is ongoing to fully understand these variants and how they affect vaccines. Learn more.
Several different vaccines have been developed for COVID-19. A few of them have made it through clinical trials and have been approved by the U.S. Food and Drug Administration (FDA). Some are still in clinical trials. Typically, at least 3,000 study participated are vaccinated in each clinical trial for a vaccine. Learn more.
Most people will have some sort of short-term reaction to the vaccine. This is normal and happens because your body is building an immune response. People may experience pain at the injection site, a sore arm, body aches, fever, fatigue, headache, or stomach issues.
mRNA vaccines have been studied over the last two decades. However, the only way to know what, if any, long-term side effects result from the use of these mRNA vaccines is to follow the participants of the clinical trials, vaccinate and study many more people, and then follow all of them for several years. The Center for Disease Control (CDC) developed a new smartphone-based tool called v-safe to increase the CDC’s ability to rapidly detect any safety issues with the COVID-19 vaccines. The CDC is also actively studying the long-term effects of COVID-19.
Allergic reactions to the COVID-19 vaccine can occur, but they are rare. The Pfizer/BioNTech and Moderna vaccines that have been approved for use in the U.S. do not contain eggs, preservatives or latex. However, if you have had an immediate allergic reaction—even if it was not severe—to a vaccine or injectable therapy for another disease, ask your doctor if you should get a COVID-19 vaccine. Your doctor will help you decide if it is safe for you to get vaccinated. For most people, though, having a bad reaction to a flu shot just means they should be monitored longer after they get the COVID-19 vaccine.
CDC recommends that people with a history of severe allergic reactions not related to vaccines or injectable medications—such as food, pet, venom, environmental, or latex allergies—get vaccinated. People with a history of allergies to oral medications or a family history of severe allergic reactions may also get vaccinated.
The CDC has provided recommendations for COVID-19 vaccination providers about how to prepare for the possibility of a severe or allergic reaction. All people who get a COVID-19 vaccine should be monitored on site. People who have had severe allergic reactions or who have had any type of immediate allergic reaction to a vaccine or injectable therapy should be monitored for at least 30 minutes after getting the vaccine. All other people should be monitored for at least 15 minutes after getting the vaccine. Learn more.
Talk to your healthcare provider or pharmacist about the medication you are taking.
The COVID-19 vaccines being distributed in the U.S. have been found to be both effective and safe for most people. Vaccines work by creating an immune response in our bodies. This immune response does more than just create antibodies against a disease: It primes our bodies to fight an infection. Sometimes, these changes can affect how the cells in our bodies use the medications we take. The chance of a negative reaction between the vaccine and any medication is extremely small. Taking medication is not a reason to delay getting the COVID-19 vaccine.
No, the COVID-19 vaccine will not give you COVID-19. Vaccines teach our immune systems how to recognize and fight the virus that causes COVID-19. Sometimes this process can cause symptoms such as pain at the injection site, a sore arm, body aches, fever, fatigue, headache, or stomach issues. These symptoms are normal and a sign the body is building immunity. It typically takes a few weeks for the body to build immunity after vaccination. That means it’s possible a person could be infected with the virus that causes COVID-19 just before or just after vaccination and get sick. This is because the vaccine has not had enough time to provide protection.
Vaccines currently in clinical trials in the U.S., along with vaccines that have already been approved for use in the U.S., will not cause a positive test result from a viral COVID-19 test. Viral tests are used to see if you have a current infection. In this case, the answer to the question is no.
If your body develops an immune response, which is the goal of vaccination, there is a possibility you may test positive on some antibody tests. Antibody tests indicate you had a previous infection and may have some level of protection against the virus. Experts are currently working to assess how COVID-19 vaccination may affect antibody testing results. In this case, the answer to the question is maybe.
It typically takes a few weeks to build immunity after receiving a vaccine. That means it is possible a person could be infected with the virus that causes COVID-19 just before or just after vaccination and still get sick. In this case, the person would test positive for COVID-19 shortly after getting the vaccine.
As is the length of time someone who was ill with COVID-19 remains immune, how long COVID-19 vaccine gives someone immunity is also not yet known. Data from clinical trials will be used to find out how long immunity will last and if a yearly booster dose of vaccine will be needed. As experts continue to study the vaccine, we will continue to learn more. However, building immunity from a vaccine is a much safer option.
The first COVID-19 vaccines that have been approved for use in the U.S. require two doses. Doses of the Pfizer-BioNTech vaccine should be given 21 days apart. The Moderna vaccine should be given 28 days apart. The different vaccine products will NOT be interchangeable. The second dose must be completed with the same vaccine brand as the first dose received.
All but one of the COVID-19 vaccines that are currently in Phase 3 clinical trials in the U.S. use two shots. The first shot starts building protection. A second shot a few weeks later is needed to get the most protection the vaccine has to offer. One vaccine in Phase 3 clinical trials only needs one shot. Learn more.
Individuals who choose to be vaccinated will be given the same vaccine for both doses. These mRNA COVID-19 vaccines are not interchangeable with each other or with other COVID-19 vaccine products. The safety and efficacy of a mixed-product series have not been evaluated. Both doses of the series should be completed with the same product. Learn more.
Yes. As long as a person has recovered from the acute symptoms of SARS-CoV-2, and meets the criteria to discontinue isolation, it is safe for them to get the vaccine. Learn more.
The protection someone gets from having an infection, called natural immunity, varies depending on the disease and from person to person. Since this virus is new, it is unknown how long natural immunity will last. As experts continue to study both the virus and the vaccines, we will continue to learn more. However, building immunity from a vaccine is a much safer option than to risk the complications from becoming ill from COVID-19.
At this time, experts do not know what percentage of people need to be vaccinated to reach herd immunity to COVID-19. “Herd immunity” is when enough people have protection from either a previous infection, or have had a vaccination for that infection, to prevent the spread of an illness among the community. As a result, everyone within the community is protected even if some people don’t have any protection themselves. The percentage of people who need to have protection in order to achieve herd immunity varies by disease.
Stopping a pandemic requires using all the tools we have available. Wearing masks and social distancing help reduce your chance of being exposed to the virus or spreading it to others, but these measures are not enough. Vaccines will work with your immune system so it will be ready to fight the virus if you are exposed. Vaccination will help you from getting COVID-19, and is a safer way to build protection than becoming sick with COVID-19. However, the combination of getting vaccinated and following recommendations to protect yourself and others will offer the best protection from COVID-19.
No. All of our mitigation strategies remain the same. These mitigation strategies are even more important, essential, and urgent in light of the new COVID-19 variants. Some of the new variants appear to spread more easily and quickly than the original SARS-CoV-2 virus.
Mask mandates are issued by state and local governments rather than by CDC or other parts of the federal government. Mask mandates have been demonstrated to be effective in reducing community transmission of COVID-19 and relieving pressure on hospitals and the health system from COVID-19 cases. Maintaining widespread, correct use of face masks is one of the most important things we can do to keep schools open, further open our economy, and get so many unemployed persons back to work. Until there is low community transmission of COVID-19, more people vaccinated, and restoration of full economic activity, CDC will likely continue to recommend community use of face masks. Based on CDC recommendations plus the levels of community transmission of the virus, state and local governments will make decisions about whether to mandate mask use for their jurisdiction.
The Immunization Registry Information System (IRIS) is a tool that has been used by vaccine providers for many years. IRIS provides computerized tracking of immunizations for children, adolescents and adults who are seen in a variety of public and private health settings throughout the state. The IRIS program is able to document individual immunizations, track vaccine usage and vaccine distribution. Learn more.
No. There is no vaccine microchip, and the vaccine will not track people or gather personal information into a database. Nor does the vaccine have the ability to control your mind.
This myth started after comments made by Bill Gates from The Gates Foundation about a digital certificate of vaccine records. The technology he was referencing is not a microchip, has not been implemented in any manner and is not tied to the development, testing or distribution of COVID-19 vaccines. Learn more.
No. Like most vaccinations, the vaccine is injected into your muscle. This is a “one way ride” and nothing is pulled back into the syringe. Needles used to administer vaccine are properly disposed of into a medical grade sharps container.
mRNA COVID-19 vaccines also do not change or interact with your DNA in any way. Messenger RNA vaccines-also called mRNA vaccines- are the first COVID-19 vaccines authorized for use in the U.S. mRNA vaccines teach our cells how to make a protein that triggers an immune response. The mRNA from a COVID-19 vaccine never enters the nucleus of the cell, which is where our DNA is kept. This means the mRNA cannot affect or interact with our DNA in any way. Instead, mRNA COVID-19 vaccines work with the body’s natural defenses to safely develop immunity to disease. Learn more.
Local vaccine providers are working to make sure you receive your vaccine and will be patient in this process. A scammer may not be! Local vaccine providers are reaching out to eligible patients in multiple ways. This includes by mail, phone, text, email, or messaging such as MyChart to offer appointments. Vaccine providers will:
It is possible a vaccine provider will need to verify your social security number, leave a message, or send an email asking you to contact them.
Our local area agency on aging reported a scam in Iowa where someone calls to offer older Iowans the opportunity to buy a ticket to guarantee a space on the waiting list. The FBI has also warned the public to be aware of activities that indicate fraudulent activity. Learn more.